NAME OF THE DRUG

ACTION OF DRUG WHY ORDERED FOR THE PATIENT Binds to an enzyme on gastric parietal cells in the presence of acidic gastric pH, preventing the final transport of hydrogen ions into the gatric lumen.

SIDE EFFECTS ADVERSE EFFECT

PATIENTS ASSESSMENT

HOW WILL YOU KNOW THAT THE DRUG IS EFFECTIVE FOR THE PATIENT

PATIENT TEACHING NURSING RESPONSIBILITIES

Generic name: Omeprazole Dosage: 40mg Frequency: TID

CNS: weakness, dizziness, headache, somnolence, fatigue. CV: chest pain. GI: abdominal pain, acid regurgitation, constipation, diarrhea, flatulence, nausea, vomiting. Derm: rash, itching

Instruct patient to take medication as directed for the full course of therapy, even if feeling better. If a dose is missed it should be taken as soon as remembered, but not if almost time for next dose. Do not double doses. May cause occasional drowsiness or dizziness. Advise to avoid alcohol. Laboratory Result pH: Serum creatinine: Occult blood:

Decrease in abdominal pain or prevention of gastric irritation and bleeding. Healing of duodenal ulcers can be seen of x-ray examination or endoscopy. Decrease in symptoms of gastroesophageal reflux disease. Therapy is continued for 4 to 8 weeks after initial episode

Assess patient routinely for epigastric or abdominal pain and frank or occult blood in stool, emesis or gastric aspirate. Lab test: CBC with differential should e monitored periodically throughout therapy. May cause eleveated AST.

N: Rebamipide R: PO D: 100mg/tab F: tid

Increases gastric blood flow, prostaglandin biosynthesis and decrease free oxygen radicals. Indicated for the treatment of gastric

Rash Pruritus Diarrhea Constipation Nausea Vomiting

Monitored client for any drug induced adverse reactions during the therapy Monitored Vital signs Instructed client and relatives to take drug only as